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Chromatin remodeling through histone posttranslational modifications (PTMs) and DNA methylation has recently been implicated in
cognitive functions, but the mechanisms involved in such epigenetic regulation remain poorly understood. Here, we show that protein
phosphatase 1 (PP1) is a critical regulator of chromatin remodeling in the mammalian brain that controls histone PTMs and gene
transcription associated with long-term memory. Our data show that PP1 is present at the chromatin in brain cells and interacts with
enzymes of the epigenetic machinery including HDAC1 (histone deacetylase 1) and histone demethylase JMJD2A (jumonji domain-
containing protein 2A). The selective inhibition of the nuclear pool of PP1 in forebrain neurons in transgenic mice is shown to induce
several histone PTMs that include not only phosphorylation but also acetylation and methylation. These PTMs are residue-specific and
occur at the promoter of genes important for memory formation like CREB (cAMP response element-binding protein) and NF-B
(nuclear factor-B). These histone PTMs further co-occur with selective binding of RNA polymerase II and altered gene transcription,
and are associated with improved long-term memory for objects and space. Together, these findings reveal a novel mechanism for the
epigenetic control of gene transcription and long-termmemory in the adult brain that depends on PP1.
Introduction
Chromatin remodeling is an important epigenetic mechanism
for the regulation of gene transcription (Jaenisch and Bird, 2003;
Williams and Tyler, 2007). In the brain, it was recently demon-
strated to be critical for learning, the formation of long-term
memory (LTM) (Guan et al., 2002; Alarco´n et al., 2004; Levenson
et al., 2004; Chwang et al., 2006, 2007; Fischer et al., 2007; Miller
and Sweatt, 2007; Miller et al., 2008), the maintenance of neuro-
nal plasticity (Duman and Newton, 2007), and neuroadaptation
in depression (Tsankova et al., 2007). Chromatin remodeling is a
process that dynamically regulates the accessibility of the DNA to
the transcriptionalmachinery, throughnuclearmechanisms involv-
ing posttranslational modifications (PTMs) of histone proteins and
DNA methylation. Both histone PTMs and DNA methylation are
induced by complex enzymatic machineries engaged in multiple
cross talks that establish a gene-specific histone code determining
whether a gene is activated or repressed (Jenuwein and Allis, 2001;
Kouzarides, 2007; Latham and Dent, 2007; Li et al., 2007).
Previous work has shown that histone phosphorylation and
acetylation are associated with the consolidation of associative
memory such as contextual fear and taste memory (Swank and
Sweatt, 2001; Guan et al., 2002; Alarco´n et al., 2004; Korzus et al.,
2004; Levenson et al., 2004; Chwang et al., 2006, 2007; Bredy et
al., 2007; Lubin and Sweatt, 2007; Vecsey et al., 2007; Lubin et al.,
2008). While histone acetylation is known to be mediated by
histone acetyltransferases (HATs) like cAMP response element-
binding protein-binding protein (CBP) (Alarco´n et al., 2004;
Korzus et al., 2004) and p300 (Oliveira et al., 2007), and by his-
tone deacetylases (HDACs) (Levenson et al., 2004; Vecsey et al.,
2007), histone phosphorylation engages the protein kinases
mitogen- and stress-activated protein kinase 1 (MSK1) (Chwang
et al., 2007) and extracellular signal-regulated kinase (ERK)/
mitogen-activated protein kinase (MAPK) (Chwang et al., 2006).
However, the protein phosphatase(s) that dephosphorylate his-
tones in the adult brain during memory formation have to date
not been identified. This is a major shortcoming because protein
phosphatases (PPs) are essential counterparts to protein kinases
in the regulation of the phosphorylation of numerous substrates.
Moreover, PPs are strong molecular constraints on learning and
memory (Lee and Silva, 2009) that favor forgetting (Genoux et
al., 2002) and play a role in Alzheimer’s disease (Knobloch et al.,
2007) and cognitive decline in aging (Genoux et al., 2002; Mansuy
and Shenolikar, 2006; Knobloch et al., 2007).
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Among the several PPs expressed in the nervous system, pro-
tein Ser/Thr phosphatase 1 (PP1) is one of the most likely candi-
dates to be involved in chromatin remodeling in the adult brain.
In vitro, PP1 is an important regulator of transcriptional and
translational events such as mRNA processing, splicing, and
translation initiation in several cell types (Bennett, 2005;Mansuy
and Shenolikar, 2006; Moorhead et al., 2007). On a subcellular
level, it is abundant in the nucleus in which it forms distinct
multimeric holoenzymes with specific targeting partners and
thereby regulates substrates involved in nuclear processes (Bennett,
2005). In yeast, Caenorhabditis elegans, and Xenopus during mi-
tosis, PP1 controls histone 3 (H3) dephosphorylation and can
thereby reverse the action of Aurora protein kinases (Hsu et al.,
2000; Murnion et al., 2001). In dividing kidney cells, PP1 also
influences histone acetylation, through its ability to form a com-
plex with HDAC1 and recruit it to the chromatin (Canettieri et
al., 2003; Jin et al., 2003; Brush et al., 2004). Little is known,
however, about the role of PP1 in the control of histone PTMs
in postmitotic cells such as adult neurons, in particular in the
context of memory formation. Here, we provide new evidence
that PP1 is a key regulator of histone PTMs in adult neurons
that is essential for the establishment of gene-specific histone
codes and the control of gene transcription in long-term
memory formation.
Materials andMethods
Animals
Transgenic mice carrying a fragment of the nuclear inhibitor of PP1
spanning amino acids 143–224 (NIPP1*), excluding other functional
domains of endogenous NIPP1, fused to enhanced green fluorescent
protein (EGFP) and linked to a tetO promoter were generated and
crossed with mice expressing the reverse tetracycline-controlled transac-
tivator 2 (rtTA2) under the control of the forebrain-specific Ca2/CaM-
dependent protein kinase II (CaMKII) promoter (Michalon et al.,
2005) to obtain double transgenic animals. For all experiments, adult
(3–8 months of age) NIPP1*-EGFP transgenic males fed with doxycy-
cline (dox) (6 mg per gram of food for at least 8 d; Westward Pharma-
ceuticals) were used. As controls, we used littermates carrying no
transgene or either one of the transgenes fed with dox, or NIPP1*-EGFP
mice not fed with dox. For on/off experiments, mice were treated with
dox for at least 8 d, and then dox was withdrawn and mice were tested a
minimum of 7 d later. Mice were maintained in accordance with the
Federation of Swiss Cantonal Veterinary Office and European Commu-
nity Council Directive (86/609/EEC) guidelines.
Reverse transcription–PCR
Total RNAwas isolatedwith TRIReagent (ResearchCenter) and purified
with RQ1 DNase (Promega), followed by precipitation with sodium ac-
etate and ethanol. Reverse transcriptionwas performedwith 1g of total
RNA using an Enhanced Avian HS reverse transcription (RT)-PCR kit
(Sigma-Aldrich).
Immunohistochemistry
Free-floating sections of transcardially perfused animals were incubated
with the following antibodies: GFP (1:500; Invitrogen), neuronal nuclei
(NeuN) (1:500; Sigma-Aldrich), and Cy3 goat anti-rabbit or FITC don-
key anti-mouse (1:500; Jackson ImmunoResearch Laboratories). Nu-
clear staining was performed using 4,6-diamidino-2-phenylindole
(DAPI) or hematoxylin. Organotypic hippocampal slices were double-
immunostained for EGFP expression and NeuN. Slices were fixed over-
night at 4°C in 4%paraformaldehyde in 0.1 M phosphate buffer (PB), pH
7.4, washed in 0.1 M PB (three times 1 h), and then blocked and perme-
abilized in 0.1 M PB, 0.4% Triton X-100, and 10% heat-inactivated horse
serum (HS) for 24 h at 4°C. Slices were incubated in primary antibodies
against GFP (1:1000; rabbit; Synaptic Systems) and NeuN (1:1000;
mouse; Millipore Bioscience Research Reagents) for 72 h at 4°C in 0.1 M
PB, 0.4% Triton X-100, and 10% HS, followed by overnight incubation
with goat anti-rabbit FITC and donkey anti-mouse TRITC (tetrameth-
ylrhodamine isothiocyanate) fluorescence-conjugated secondary anti-
bodies (1:1000; Jackson ImmunoResearch Laboratories). All images
were acquired with a CoolSNAP digital camera (Roper Scientific) and an
Axiophot microscope (Zeiss) and analyzed using MCID Elite 7.0 soft-
ware (MCID).
Protein phosphatase assay
Protein phosphatase assays were performed as previously described (He´-
dou et al., 2008). In brief, hippocampi were dissected and homogenized
in 3.75 mM Tris-HCl, pH 7.4, 15 mM KCl, 3.75 mMNaCl, 250 M EDTA,
50 M EGTA, 30% (w/v) sucrose, 30% (v/v) glycerol, protease inhibitor
mixture (Sigma-Aldrich), 100 M PMSF using a Dounce homogenizer,
and then centrifuged (1000 g; 10min). Supernatant (cytoplasmic frac-
tion) and pellet (nuclear fraction) were separated. Each fraction was
resuspended in the same buffer without sucrose but with 15 mM
-mercaptoethanol, homogenized using a 26 G syringe, and then puri-
fied on PiResin (Innova Biosciences). Phosphatase activity was deter-
mined by incubating 2g sample with 0.15mMRII substrate (BIOMOL)
and 5 nM tautomycin (to inhibit PP1) or 5 nM tautomycin plus okadaic
acid (OA) (to inhibit PP1 and PP2A activity) in 50mM Tris-HCl, pH 7.0,
100MNa2EDTA, 5mMDTT, and 0.01% Brij35 at 30°C for 10min. The
reaction was terminated by adding TCA followed by centrifugation
(13,000  g; 5 min). The amount of free phosphates released in the
reaction was measured with BIOMOL Green reagent (BIOMOL) at 620
nm and background subtracted. For total phosphatase activity, tautomy-
cin and OA were removed from the reaction. PP1 and PP2A activity was
calculated by the ratio of phosphatase activity with inhibitors and total
phosphatase activity.
Coimmunoprecipitation
In vitro. Homogenates from N2A (murine neuroblastoma cells) cells
grown in DMEM (containing 10% fetal calf serum) were centrifuged for
10 min at 10,000  g, and lysates were used for immunoprecipitation.
Anti-HDAC1 antibody (Abcam) was added for 1 h at 10°C, followed by
incubation with protein A-Sepharose for another hour. Precipitates were
washed once with TBS (20 mM Tris-HCl at pH 7.4 plus 150 mM NaCl)
containing 0.1 M LiCl, twice with TBS supplemented with 0.1%
NP-40, and finally with 20 mM Tris-HCl at pH 7.4 supplemented with 1
mM DTT and 0.1 mg/ml BSA, and analyzed by immunoblotting with
antibodies against PP1 (Calbiochem), HDAC1 (Cell Signaling), and
IgG (Sigma-Aldrich).
In vivo.Whole-tissue lysates were prepared by homogenization in 500
l of sterile-filtered 50 mM Tris, 120 mM NaCl, 0.5% NP-40 containing
proteinase and phosphatase inhibitors (1:100; Sigma-Aldrich), followed
by 15 min centrifugation at 14,000 rpm at 4°C and collection of the
supernatant. After 60–90min incubationwith 1–2g of the correspond-
ing antibody, 20 l of BSA-precleared pansorbin–protein A beads (Cal-
biochem)were added for 45min at 4°C, and the immune complexeswere
collected at 8000 rpm for 3 min, by one wash each in high-salt homoge-
nization buffer (containing 50 mM Tris, 500 mM NaCl, and 1% NP-40)
and regular homogenization buffer. Finally, samples were loaded on a
10–12% SDS gel and analyzed (see below, Western blotting). Immuno-
precipitation (IP) antibodies used were HDAC1 (Cell Signaling) and
PP1 (Calbiochem), and blotting antibodies used were PP1 (Calbio-
chem), HDAC1 (Cell Signaling), Jmj-C domain-containing histone de-
methylation protein 2A (JMJD2A) (Abcam), lysine-specific histone
demethylase 1 (LSD1) (Cell Signaling), and IgG (Sigma-Aldrich).
In vitro phosphorylation assay
Recombinant histoneH3 (Roche) was phosphorylated by addition of the
catalytic subunit of protein kinase A (Sigma-Aldrich), and then incu-
bated with or without the catalytic subunit of PP1, PP1 (purified from
rabbit skeletal muscle), and a NIPP1 peptide (Beullens et al., 1992). At
indicated time points, aliquots were collected, boiled in SDS lysis buffer,
and run by SDS-PAGE. The gel was stained with Coomassie blue, and
membranes were incubated with anti-phosphoH3S10 (Millipore) as de-
scribed below.
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HDAC activity assay
HDAC activity in hippocampal nuclear extracts (50 g) was determined
using a colorimetric HDAC Activity Assay kit (Abcam) and expressed as
optical density value at 405 nm/g protein. Activity in control samples
was used for normalization.
Western blotting
Ten to 15 g proteins from nuclear extracts or membrane-enriched
hippocampal preparations were prepared from freshly dissected brain
as described above (see Protein phosphatase assay) resolved on 10–
12% SDS-PAGE, and transferred onto a nitrocellulose membrane (Bio-
Rad). Membranes were blocked (Rockland IR blocking buffer;
Rockland), and then incubated in primary and secondary antibodies.
Band intensity was determined and quantified using anOdyssey IR scan-
ner (LI-CORBiosciences). The signal was normalized toH1.0 for histone
proteins and -actin for non-nuclear proteins. Values in NIPP1* trans-
genic mice were normalized to values in control littermates. The follow-
ing antibodies were used: H2B (1:2000) (Abcam), H3 (1:2000), H4 (1:
2000) (Millipore); phospho H3T3 (1:1000), phospho H3T11 (1:1000),
phospho H3S28 (1:1000), acetyl H2B (1:10,000) (Abcam); phospho
H3S10 (1:1000), acetyl H3K9 (1:1000), acetyl H3K14 (1:2000), acetyl
H4K5 (1:1000) (Millipore); dimethyl H3K4 (1:2000), trimethyl H3K36
(1:2000) (Abcam); cAMP response element-binding protein (CREB) (1:
1000), phosphoCREB S133 (1:1000) (Cell Signaling); ERK12 (1:1000),
phospho ERK12 T185T202 (1:2000), HDAC1 (1:1000), phospho
HDAC1 S421 (1:1000), MSK1 (1:1000), phospho MSK1 T581 (1:1000)
(Abcam); methyl-CpG-binding protein 2 (MeCP2) (1:2000), phospho
MeCP2 S421 (1:2000) (generously provided by M. Greenberg, Harvard
University, Cambridge, MA); GluR1 (1:1000), GluR2 (1:1000), CaMKII
(1:5000), phospho GluR1 S845 (1:1000), phos-
pho GluR2 S880 (1:1000), phospho CaMKII
S246 (1:5000) (Millipore); H1.0 (1:1000)
(Abcam); -actin (1:4000) (Sigma-Aldrich);
goat anti-rabbit (IRDye 680 nm; 1:10,000) and
goat anti-mouse (IRDye 800 nm; 1:10,000)
(LI-COR Biosciences).
Quantitative RT-PCR
Total RNAwas extracted using the NucleoSpin
Kit II (Macherey-Nagel), purified with RQ1
DNase (Promega), and reverse-transcribed us-
ing the SuperScript First-Strand Synthesis Sys-
tem for RT-PCR II (Invitrogen). Quantitative
PCR was performed using TaqMan probes
(Applied Biosystems) and an Applied Biosys-
tems 7500 Thermal Cycler. Each sample was
quantified three times, and equal amounts of
cDNA were analyzed in triplicate for each run.
Values were chosen in the linear range of am-
plification and the comparative Ctmethodwas
used to assess differences in gene expression be-
tween samples (Livak and Schmittgen, 2001).
-Actin was used as internal control.
Lentivirus preparation and injection in
hippocampal slices
For neuron-specific expression of PP1, the
lentiviral vector pLVPRT-tTRKRAB (Szulc et
al., 2006) (kindly provided by D. Trono, Swiss
Federal Institute of Technology, Lausanne,
Switzerland) was used to generate pLVPRT-
tTRKRAB-PP1-EGFP. PP1 fused to EGFP
(PP1-EGFP) was excised from pEGFP-C1-
PP1 (Ceulemans et al., 2002) (obtained from
S. Shenolikar, Duke University, Durham, NC)
and subcloned between the MluI and SmaI
sites of pLVPRT-tTRKRAB. The construct was
sequenced before proceeding to the PP1-
EGFP virus production as previously de-
scribed (Szulc et al., 2006). Virus was titrated
by physical particle determination with a p24
ELISA test (HIV-1 P24 ELISA; NEK050; PerkinElmer). Organotypic hip-
pocampal slices from NIPP1*-EGFP mutant and control mice were cul-
tured in vitro using the roller tube technique. After 2 weeks in culture, the
slices were injected with PP1-EGFP viral solution (1.15  109 TU/
ml) or artificial CSF (aCSF) as control. Typically, each slice was injected
5–10 times with 2 l of the virus solution/aCSF. After injection, slices
were returned to the roller tubes and supplementedwith penicillin/strep-
tomycin (1:500) for at least 1 week. On the day before additional process-
ing, the culture medium was replaced with medium containing 1 g/ml
doxycycline to induce PP1-EGFP expression.
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed as described by
Tsankova et al. (2004) with the following modifications. After cross-
linking, samples were spun down at 1500 rpm for 5 min at 4°C, and the
pellet was washed twice with ice-cold PBS containing proteinase inhibi-
tors (Complete; Roche). Samples were then homogenized in cell lysis
buffer containing proteinase and phosphatase inhibitors (1mM-glycer-
ophosphate, 10 mM NaF, 0.1 mM Na3VO4) with 10 strokes on ice in a
Dounce homogenizer, and then in nuclear lysis buffer containing the
same proteinase and phosphatase inhibitors by pipetting. Samples were
sonicated on ice using a Branson Digital Sonifier with 15 cycles at 50%
power setting of 10 s each. A total of 100g per sample was used for each
ChIP reaction in IP buffer (0.1% SDS, 1%Triton X-100, 150mMNaCl, 2
mM EDTA, pH 8, 20mMTris-Cl, pH 8.0, containing the same inhibitors)
and immunoprecipitated overnight at 4°C with 5 g of the correspond-
ing antibodies (see above, Western blotting) and anti-IgG (Sigma-
Aldrich) as a negative control. For PP1 and RNA polymerase II (RNA
Figure 1. Inducible and neuron-specific inhibition of nuclear PP1 in the adult mouse forebrain. a, Schematic representation of
the NIPP1* fragment containing the PP1 inhibitory domain and nuclear localization signal (amino acids 143–224; red box)
expressed as a transgene. b, Schematic of the transgenes used to express NIPP1* inducibly in forebrain neurons. NIPP1*-EGFP
expression is induced by doxycycline (Dox) (On). c, RT-PCR examining NIPP1* and EGFP expression in cortex (Ctx), hippocampal
formation (Hip), amygdala (Amy), andhypothalamus (Hyp) in adultmutantmice treatedwithdoxornot.d, Immunohistochemical
staining showing NIPP1*-EGFP colocalization with the neuronal marker NeuN in nuclei (NIPP1*-EGFP, green/NeuN, red), and
nuclear counterstaining with hematoxylin (NIPP1*-EGFP, brown/Hemat, blue). Scale bar, 20 m. e, Decreased PP1 activity
in nuclear (n 7) but not cytoplasmic (n 5) hippocampal extracts from NIPP1*-EGFP mice compared with control littermates
(nuclear, n 11; cytoplasmic, n 7). Nuclear PP1 activity, F(1,15) 11.24, **p 0.01; cytoplasmic activity, F(1,12) 1.14, p
0.31. Error bars indicate SEM.
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Pol II) ChIP assays, PP1 (Calbiochem) and
RNA polymerase II CTD (YSPTSPS) repeat
(Abcam) was used. After IP, DNA–histone
complexes were collected with 40 l of 10%
BSA/salmon sperm DNA (Stratagene)-
precleared protein A/Sepharose beads (GE
Healthcare) for 2 h at 4°C. The sample/bead
mixtures were washed twice with wash buffer
(0.1% SDS in IP buffer), once with final wash
buffer (0.1% SDS, 1% Triton X-100, 0.5 M
NaCl, 2 mM EDTA, pH 8.0, 20 mM Tris-Cl, pH
8.0, containing proteinase inhibitors), and
twice with TE (10 mM Tris-Cl, pH 8.0, 1 mM
EDTA). DNA and histones were dissociated by
incubation in 1% SDS in TE for at least 4 h at
65°C. Finally, proteins were digested with pro-
teinase K (Sigma-Aldrich) for 1 h at 45°C, and
the DNA was extracted with phenol/chloro-
form/isoamyl alcohol (Fluka) and resuspended
in 100 l of TE. ChIP experiments were run at
least in biological triplicates. To quantify
histone-associated DNA, real-time PCR of IP
samples was performed on an Applied Biosys-
tems 7500 Thermal Cycler using gene-specific
primers (supplemental Table 1, available at
www.jneurosci.org as supplemental material)
and SYBR green (QIAGEN) with the following
cycling conditions: 15 min at 95°C, 45 cycles of
15 s at 94°C, 30 s at 60°C, and 1 min at 72°C.
Data were collected in the linear amplification
range. Relative quantification was estimated as
described previously (Chakrabarti et al., 2002)
with -tubulin and -globin as control genes.
Each PCR was repeated at least twice.
Behavior
The novel object recognition task was con-
ducted as previously described (Genoux et al.,
2002). Briefly, mice were placed in an arena
containing three unknownobjects that they ex-
plored during 5 sessions of 5 min. Memory for
the objects was tested by exposing the animal to
two of the now familiar objects and one novel
object. Discrimination ratio was calculated as
the percentage of exploration of the novel ob-
ject defined asDR tnovel/(tnovel (tfamiliar1
tfamiliar2)), where tnovel is the time spent with
the novel object (in seconds), and tfamiliar is the
time spent with familiar objects 1 and 2 (in
seconds). For molecular analyses, mice were killed 2 min after their last
behavioral session. The Morris water maze was conducted as described
previously (Malleret et al., 2001). During training, mice were allowed to
swimuntil they reached thehiddenplatformor for amaximumof90 s. If the
animals did not find the platform, they were gladly placed on it for 15 s. On
testing day, mice were put in the water without the platform for 60 s.
Statistics
ANOVAs and univariate or multivariate general linearized model were
used to determine genotype and treatment effect. Tukey’s or least signif-
icant difference (LSD) post hoc analyses were conducted when appropri-
ate. ChIP data were analyzed using two-tailed paired t tests. Statistical
significance was set at *p 0.05, **p 0.01, and ***p 0.001. All values
are expressed as mean SEM.
Results
Reversible and neuron-specific inhibition of nuclear PP1 in
the adult forebrain
To investigate the functions of PP1 in chromatin remodeling and
examine whether it contributes to the epigenetic regulation of
learning andmemory, we generated a transgenicmousemodel in
which PP1 can be selectively inhibited in the nucleus of forebrain
neurons.We hypothesized that the inhibition of the nuclear pool
of PP1 should alter histone PTMs in neurons, and have an impact
on gene transcription associated with long-term memory. We
used a fragment of the nuclear inhibitor of PP1, NIPP1 (termed
NIPP1* hereafter) (Jagiello et al., 2000), which contains a PP1
inhibition domain and a nuclear localization signal, but excludes
other NIPP1 domains such as those for DNA binding and RNA
splicing (Fig. 1a). NIPP1* was expressed inducibly and reversibly
under the control of the dox-dependent rtTA2 (Michalon et al.,
2005) and the CaMKII promoter (Fig. 1b). In the resulting dou-
ble transgenicmice (NIPP1*-EGFP), NIPP1*was predominantly
expressed inmajor forebrain structures including the hippocam-
pal formation (supplemental Fig. 1a, available at www.jneurosci.
org as supplemental material) and cortex, and marginally in the
amygdala (Fig. 1c, left panel). It was absent from non-forebrain
structures such as the hypothalamus and brainstem (Fig. 1c; sup-
Figure 2. Nuclear PP1 interacts with the epigenetic machinery. a, Representative Western blot showing coimmunoprecipita-
tion of H3 and PP1 using a PP1 antibody in NIPP1*-EGFP mice and control littermates in the adult hippocampus. b, Direct
dephosphorylation of histoneH3 in vitro.Western blot showing S10 phosphorylation onH3by protein kinase A (control) incubated
with the catalytic subunit of PP1 ( PP1), or with PP1 and NIPP1 ( PP1, NIPP1) for 0, 5, 10, or 30 min. Top panel, Anti-
phospho H3S10; bottom panel, loading control (Coomassie blue gel staining after SDS-PAGE). c, Representative Western blot
showing decreased PP1/HDAC1 interaction in HDAC1 immunoprecipitates in the presence of NIPP1* in vitro (top panel), and in the
hippocampus of NIPP1*-EGFP mice (bottom panel). d, HDAC activity is decreased in nuclear (n 7) but not cytoplasmic (n 3)
hippocampal extracts from NIPP1*-EGFP mice when compared with control littermates (nuclear, n 7; cytoplasmic, n 3);
nuclear HDAC activity, F(1,12) 32.02, ***p 0.001; cytoplasmic, n.s., data are normalized to control littermates. Error bars
indicate SEM. e, Representative Western blot showing decreased PP1/JMJD2A interaction in PP1 immunoprecipitates in the
hippocampus of NIPP1*-EGFP mice. f, Representative Western blot showing no difference in PP1/LSD1 interaction in PP1 immu-
noprecipitates between control and mutant mice. Co-IP data are representative of at least three independent experiments.
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plemental Fig. 1b, available at www.jneurosci.org as supplemen-
tal material). NIPP1* expression was not induced in the absence
of dox (Fig. 1c, right panel). At a subcellular level, NIPP1* was
restricted to the nucleus of neuronal cells and was absent from
other subcellular compartments (Fig. 1d; supplemental Fig. 1c,
available at www.jneurosci.org as supplemental material). Con-
sistently, it significantly inhibited PP1 activity only in nuclear,
but not cytoplasmic fractions (Fig. 1e). This inhibition was spe-
cific to PP1 and did not affect PP2A, a structurally related PP
(supplemental Fig. 2, available at www.jneurosci.org as supple-
mental material).
Nuclear PP1 is part of the epigenetic machinery in the brain
To determine the involvement of nuclear PP1 in chromatin re-
modeling in the brain, we tested whether the inhibition of PP1
alters the association of PP1 with the chromatin and the epige-
netic machinery, in particular with histone-modifying enzymes.
Although in vitro, PP1 was shown to be recruited to histone pro-
teins, specifically H3 (Trinkle-Mulcahy et al., 2006), it is not
known whether this interaction also oc-
curs in the brain in vivo. We first exam-
ined whether PP1 associates with the
chromatin by coimmunoprecipitation
(co-IP) assays using an antibody against
PP1, a nuclear isoform of PP1 (Moor-
head et al., 2007). These assays showed
that nuclear PP1 does bind to H3 in the
adult mouse forebrain (Fig. 2a, control).
These results were confirmed with an
anti-H3 antibody (data not shown). Next,
we tested whether this interaction is func-
tionally important and examined whether
it correlates with H3 dephosphorylation.
In vitro, the binding to the chromatin was
associated with dephosphorylation of
serine 10 (S10) on H3 (Fig. 2b, middle
panel), and this dephosphorylation was
abolished when PP1 was inhibited by
NIPP1 (Fig. 2b, right panel). Notably, in
the adult brain, PP1 binding to H3 was
globally not altered by NIPP1* expres-
sion (Fig. 2a, NIPP1*-EGFP), probably
because the binding of PP1 to the chro-
matin is not altered overall, but only at
specific loci.
Since PP1 was reported to associate
with HDACs in vitro (Canettieri et al.,
2003; Brush et al., 2004), we next tested
whether this association also occurs in the
adult brain and whether it is perturbed by
NIPP1* expression. Co-IP assays showed
that the level of HDAC1 associated with
PP1 was decreased by PP1 inhibition,
both in vitro and in vivo (Fig. 2c), and that
this correlated with reduced HDAC activ-
ity selectively in the nucleus, but not in the
cytoplasm of nuclear forebrain extracts
(Fig. 2d). Furthermore, because histone
phosphorylation and acetylation are
known to cross talk with histone methyl-
ation and often cooccur with this PTM
(Latham and Dent, 2007; Ooi and Wood,
2007), we also tested the association of
PP1 with histone demethylases (HDMs). We observed that PP1
interacts with both JMJD2A and LSD1, but that only its interac-
tion with JMJD2A, and not with LSD1, is reduced by PP1 inhibi-
tion (Fig. 2e,f). Although JMJD2A activity could not be
measured because no specific assay is available, the reduced
interaction with PP1 suggests that its activity might be de-
creased, similar to HDAC activity. Together, these results
strongly suggest that PP1 inhibition results in the displace-
ment of PP1 from HDAC1 and JMJD2A, and that, further to
H3 phosphorylation, PP1 inhibition alters histone acetylation
and methylation.
Inhibition of nuclear PP1 alters multiple histone PTMs
Based on these biochemical data, we next investigated whether
the inhibition of nuclear PP1 alters histone PTMs.We performed
a series ofWestern blot analyses in the hippocampus, a brain area
in whichNIPP1* expression is abundant in themutantmice (Fig.
1c). We first tested H3S10 phosphorylation, a histone PTM reg-
ulated by PP1 in vitro (Hsu et al., 2000; Murnion et al., 2001) and
Figure 3. Increase in specific histone PTMs by inhibition of nuclear PP1 and reversal by PP1 overexpression in hippocampus.
a, b, Representative Western blots (a) and corresponding quantitative analyses (b) of phosphorylation of H3T3 (control, n 10;
NIPP1*-EGFP, n 9), H3S10 (control, n 11; NIPP1*-EGFP, n 10; F(1,19) 8.57, p 0.01), H3T11 (control, n 10;
NIPP1*-EGFP, n 9), H3S28 (control, n 10; NIPP1*-EGFP, n 9), acetylation of H3K9 (control, n 8; NIPP1*-EGFP, n 9),
H3K14 (control, n 9; NIPP1*-EGFP, n 12; F(1,19) 7.59, p 0.05), H4K5 (control, n 6; NIPP1*-EGFP, n 5; F(1,9) 5.62,
p 0.05), H2B (control, n 8; NIPP1*-EGFP, n 8; F(1,14) 7.32, p 0.05), dimethylation of H3K4 (control, n 5–8;
NIPP1*-EGFP, n 5–9), and trimethylation of H3K36 (control, n 8; NIPP1*-EGFP, n 11; F(1,17) 7.91, p 0.05) in nuclear
extracts from the hippocampus (including CA1, CA3, and dentate gyrus) in behaviorally naive mice. Data are normalized to levels
of total H1.0. c, d, Representative Western blots (c) and quantitative analyses (d) of histone PTMs in hippocampus injected with
aCSF in control slices (control, n 2–3 slices from 4 to 5 control mice), in NIPP1*-EGFP slices expressing injected with aCSF
(NIPP1*, n 2–3 slices from 3 to 4 NIPP1*-EGFP mice), in control slices injected with PP1-EGFP (PP1, n 2–3 slices from 4
to 5 control mice), and in NIPP1*-EGFP slices injectedwith PP1-EGFP (PP1NIPP1*, n 2–3 slices from 4 to 5 NIPP1*-EGFP
mice). Phosphorylation of H3S10, F(3,12) 8.18, p 0.01; LSD post hoc, control versus NIPP1*, p 0.01; control versus PP1,
p 0.01; control versus PP1 or PP1NIPP1*, n.s; acetylation of H3K14, F(3,12) 8.11, p 0.01; LSD post hoc, control versus
NIPP1*,p0.05; control versus PP1,p0.01; control versus PP1 or PP1NIPP1*, n.s; acetylation of H4K5, F(3,11)4.23,
p 0.01; LSD post hoc, control versus NIPP1*, p 0.05; control versus PP1, p 0.01; control versus PP1 or PP1NIPP1*,
n.s; trimethylation of H3K36, F(3,12) 13.40, p 0.01; LSD post hoc, control versus NIPP1*, p 0.05; control PP1, p 0.01;
control versus PP1 or PP1 NIPP1*, n.s.; acetylation of H3K9 and dimethylation of H3K4, n.s. Data were first normalized to
levels of total H1.0., and then to control slices injected with aCSF. Error bars indicate SEM. *p 0.05, **p 0.01.
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induced by contextual fear memory
(Chwang et al., 2006, 2007). H3S10 phos-
phorylation was increased in the mutant
mice and remarkably, this increase was
specific to S10 and not observed on
other H3 residues including threonine 3
(T3), T11, or S28 (Fig. 3a,b). Moreover,
this increased phosphorylation was spe-
cific to nuclear proteins and did not oc-
cur on synaptic proteins known to be
PP1 targets (Soderling and Derkach,
2000) such asGluR1,GluR2, andCaMKII
(supplemental Fig. 3a,b, available at www.
jneurosci.org as supplemental material).
Finally, within the nucleus, phosphoryla-
tion was specific to histone proteins since
it was not altered on other nuclear pro-
teins including the transcription factor
CREB, the chromatin regulators HDAC1
and MeCP2, or the protein kinases MSK1
and ERK/MAPK (supplemental Fig. 3c,d,
available at www.jneurosci.org as supple-
mental material). Since both MSK1 and
ERK/MAPKneed to be phosphorylated to
be active (Sweatt, 2001; Arthur, 2008),
these results suggest that the increase in
H3 phosphorylation is not attributable to
altered kinase activity, but most likely to
PP1 inhibition.
Since the interaction between PP1 and
HDAC1 is perturbed, and HDAC activity
is decreased by inhibition of nuclear PP1
(Fig. 2c,d), we next examined whether
histone acetylation was also affected.
Western blot analyses using anti-acetyl
histone antibodies showed that acetyla-
tion of H2B, H3 lysine 14 (H3K14), and
H4K5 was increased in the transgenic
mice (Fig. 3a,b). Acetylation of H3K9
was, however, not changed, presumably
because of steric hindrance with S10
phosphorylation (Edmondson et al.,
2002). Furthermore, based on our obser-
vation that PP1 also interacts with the
HDMs JMJD2A and LSD1, we examined H3K36 trimethylation
(3meH3K36) and H3K4 dimethylation (2meH3K4), PTMs
known to be controlled by these demethylases, respectively
(Klose and Zhang, 2007). Trimethylation of H3K36 was signifi-
cantly increased but dimethylation of H3K4 was not changed
(Fig. 3a,b), consistent with co-IP results showing that JMJD2A
but not LSD1, was displaced from PP1.
To confirm that PP1 is sufficient to induce these histone
PTMs, we next tested whether an increase in PP1 activity has
an opposite effect. PP1 was overexpressed in hippocampal
slices from control and NIPP1*-EGFP animals using a lentivi-
ral vector (supplemental Fig. 4, available at www.jneurosci.org
as supplemental material), and the effect on histone PTMs was
assessed. Western blot analyses showed that PP1 overexpres-
sion induced a dephosphorylation of H3S10, deacetylation of
H3K14 and H4K5, and demethylation of H3K36 (Fig. 3c,d,
white bars). These changes were reversed when PP1 was in-
hibited by NIPP1* (Fig. 3c,d, white/gray striped bars), suggest-
ing that they directly resulted from increased PP1. H3K9
acetylation and H3K4 dimethylation were, however, not
changed, consistent with our previous observation that these
residues are not altered by PP1 inhibition (Fig. 3a–d). To-
gether, these results strongly suggest that nuclear PP1 controls
multiple PTMs on specific histone residues, most likely through
direct (for phosphorylation) and indirect (for acetylation and
methylation) mechanisms.
Changes in histone PTMs are associated with altered
transcription of genes involved in memory formation
Since histone PTMs contribute to the regulation of transcrip-
tional activity (Jenuwein and Allis, 2001; Kouzarides, 2007; Li et
al., 2007), we examined whether the changes in PTMs induced by
inhibition of nuclear PP1 occur at the promoter of genes impor-
tant for memory formation and whether the expression of these
genes is altered. We conducted a series of ChIP assays on the
promoter of four representative genes, CREB [a transcription
factor required for memory formation (Silva et al., 1998)], nu-
clear factor-B (NF-B) [a transcriptional regulator involved in
Figure 4. Promoter-specific histone PTMs and gene expression are altered by inhibition of nuclear PP1. a, ChIP assays showing
histone PTMs in the promoter region of CREB, NF-B, CREM, and c-Fos in the hippocampus (control, n 3–6; NIPP1*-EGFP, n
3–5): pH3S10 (CREB, t(5) 2.78, p 0.05; NF-B, t(5) 3.12, p 0.05; CREM, n.s.; c-Fos, n.s.); AcH3K9 (CREB, n.s.; NF-B, n.s.;
CREM, t(5)5.38,p0.01; c-Fos, n.s.); AcH3K14 (CREB, t(7)6.58,p0.001;NF-B, t(7)9.97,p0.001; CREM,n.s.; c-Fos,
n.s.); AcH4K5 (CREB, t(5) 3.04, p 0.05; NF-B, t(7) 3.04, p 0.05; CREM, n.s.; c-Fos, n.s.); 3MeH3K36 (CREB, t(9) 2.42,
p0.05;NF-B, t(7)7.27,p0.001; CREM,n.s.; c-Fos, n.s.).b, QuantitativeRT-PCR showingmRNAexpression in control (n
7–9) and NIPP1*-EGFP (n 5–9) mice for CREB (F(1,16) 9.84, p 0.01), CREM (n.s.), NF-B (F(1,10) 10.97, p 0.01), and
c-Fos (n.s.). c, ChIP assays showing RNA Pol II occupancy in the promoter region of CREB, CREM, NF-B, and c-Fos (control, n
3–6; NIPP1*-EGFP, n 3–4; CREB t(6) 3.07, p 0.05; CREM, n.s.; NF-B, t(6) 3.82, p 0.05; c-Fos, n.s.). d, ChIP assays
showingPP1binding to thepromoter regionof CREB, CREM,NF-B, and c-Fos (control,n3–4;NIPP1*-EGFP,n3–4; CREB,
t(6) 6.26, p 0.01; CREM, n.s.; NF-B, t(6) 3.44, p 0.05; c-Fos, n.s.). Data are normalized to control littermates. Error bars
indicate SEM. *p 0.05, **p 0.01, ***p 0.001.
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long-term memory (Meffert and Baltimore, 2005)], cAMP-
responsive element modulator (CREM) (a modulator of CREB
functions), and c-fos (an immediate-early gene), followed by
mRNA analyses by quantitative RT-PCR. ChIP assays revealed
that H3S10 phosphorylation, H3K14 and H4K5 acetylation, and
H3K36 trimethylation were increased at the CREB promoter, but
decreased at the NF-B promoter (Fig. 4a). This was accompa-
nied by increased mRNA expression of CREB but decreased
expression of NF-B (Fig. 4b). With the exception of hy-
poacetylation of H3K9 at the CREM promoter, no significant
change in histone PTMs was observed at the CREM or c-Fos
promoter, consistent with the observation that the mRNA ex-
pression of these genes was not changed (Fig. 4a,b). The ob-
servation that H3K9 acetylation was reduced in the promoter
region of CREM, but the mRNA expression unchanged, sug-
gests that H3K9 acetylation has no significant impact on
CREM expression.
Consistent with the gene expression data, ChIP assays further
demonstrated that the occupancy of RNA Pol II was increased
at the CREB promoter but decreased at the NF-B promoter,
although not changed at the CREMand c-Fos promoter (Fig. 4c).
These results confirm a link between the effect of histone PTMs
on chromatin decondensation, RNA Pol II binding, and gene
transcription. Finally, although the binding of PP1 to H3 was
overall not altered by inhibition of nuclear PP1 (Fig. 2a), we
examined whether PP1 binding is altered at specific promoters in
correlation with the changes in histone PTMs.Wemeasured PP1
occupancy at the CREB, NF-B, CREM, and c-Fos promoter by
ChIP assays, and found that PP1 binding correlates with changes
in histone PTMs. It was almost absent at the CREB promoter, but
significantly increased at theNF-Bpromoter andnot changed at
the CREM and c-Fos promoter (Fig. 4d).
These results overall suggest that the pres-
ence of PP1 at the chromatin regulates
gene transcription through histone
PTMs.
Inhibition of nuclear PP1 enhances
several forms of LTM
Since nuclear PP1 is inhibited in hip-
pocampal and cortical structures in the
mutant mice, we examined whether the
formation of memories that depend on
these structures is affected. We first tested
object recognition, a form of memory
known to recruit the hippocampus and
perirhinal cortex (Broadbent et al., 2004).
Mutant mice and control littermates were
trained to recognize three unfamiliar ob-
jects, and then tested for their ability to
discriminate these objects from a novel
object 10 min or 24 h after training. Both
groups of mice had comparable perfor-
mance during training (supplemental Fig.
5a, available at www.jneurosci.org as sup-
plemental material), but the mutant mice
could discriminate the familiar and novel
objects significantly better than control
littermates 24 h after training (Fig. 5a;
supplemental Fig. 5b, available at www.
jneurosci.org as supplemental material).
This improvementwas observed after 24 h
and not after 10min, indicating a selective
effect on LTM (Fig. 5b; supplemental Fig. 5b, available at www.
jneurosci.org as
supplementalmaterial). This effectwas confirmedon another form
of hippocampus-dependent LTM, spatial memory, using a water
maze. On this task, mice need to learn and remember distal cues
around a circular tank filled with opaque water to find an invisi-
ble escape platform. Mutant mice and control littermates had
comparable performance during acquisition (supplemental Fig.
5c, available at www.jneurosci.org as supplemental material).
However, 1 d after training, mutant mice covered a longer dis-
tance, had a more precise search (increased platform crossings),
and spent more time searching for the platform in the target
quadrant than control littermates (Fig. 5c; supplemental Fig. 5d,e,
available at www.jneurosci.org as supplemental material), sug-
gesting improved long-term spatial memory. Importantly, for
both object recognition and spatial memory, the improvement
was not observed in the absence of NIPP1* (mutant off) (supple-
mental Fig. 5b,d,e, available at www.jneurosci.org as supplemen-
tal material) or when NIPP1* expression was suppressed by dox
withdrawal (on/off) (Fig. 5), suggesting a direct effect of PP1
inhibition. Furthermore, the memory improvement was not at-
tributable to any change in overall exploratory activity since total
movement, time spent in center, and rearing behavior in an open
field were similar in mutant mice and control littermates (sup-
plemental Fig. 5f, available at www.jneurosci.org as supplemental
material). Together, these results indicate that inhibition of nu-
clear PP1 improves several forms of LTM.
Specific histone PTMs are induced in LTM
Finally, to determine whether the epigenetic changes associated
with inhibition of nuclear PP1 are relevant tomemory formation,
Figure 5. Object recognition and spatial memory are improved by inhibition of nuclear PP1. a, Object discrimination ratio in
NIPP1*-EGFP (n 8) and control littermates (n 10) treatedwith dox (F(1,16) 5.82, p 0.05) (left panel) and inNIPP1*-EGFP
(n  7) and control littermates (n  6) on/off dox (n.s.) 1 d after training (right panel). b, Object discrimination ratio in
NIPP1*-EGFP (n 8) and control littermates (n 7) treated with dox (n.s.) (left panel) and in NIPP1*-EGFP (n 6) and control
littermates (n6) on/off dox (n.s.) 10minafter training (right panel). c, Left panels, Spatialmemoryon thewatermazeevaluated
by the distance traveled in the target quadrant in NIPP1*-EGFP (n 7) and control littermates (n 8) treatedwith dox (F(1,13)
5.39; p 0.05) (left) and in NIPP1*-EGFP (n 3) and control littermates (n 6) on/off dox (n.s.) (right) 1 d after the end of
training. Middle panels, Spatial memory measured by the number of platform crossings in NIPP1*-EGFP (n 7) and control
littermates treated with dox (n 8) (F(1,13) 12.05; p 0.01) (left) and in NIPP1*-EGFP (n 3) and control littermates (n
6) on/off dox (n.s.) (right) 1 d after the end of training. Right panels, Spatialmemorymeasured by time spent in target quadrant in
NIPP1*-EGFP (n 7) and control littermates treated with dox (n 8) (F(1,13) 5.93; p 0.05) (left) and in NIPP1*-EGFP (n
3) and control littermates (n 6) on/off dox (right) 1 d after the end of training; behavioral data are representative of aminimum
of two experiments on each task using independent groups of mice. Error bars indicate SEM. *p 0.05, **p 0.01.
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we examined their correlation with LTM
using a new group of animals on the ob-
ject recognition test. We focused on his-
tone PTMs at theCREBpromoter because
CREB is specifically linked to long-term
memory (Silva et al., 1998; Josselyn et al.,
2001) and conducted a series of ChIP as-
says in the hippocampus 24 h after train-
ing. In control mice, H3S10
phosphorylation and H3K14 acetylation
were increased in correlation with LTM,
whereas H3K9 andH4K5 acetylation, and
H3K36 trimethylation were not changed
in the promoter region of CREB (Fig. 6a,
black lines; supplemental Fig. 6, available
at www.jneurosci.org as supplemental
material). This increase correlated with
enhanced CREB expression (Fig. 6b, black
bars), suggesting a link between these his-
tone PTMs, CREB expression, and LTM.
In the mutant mice, H3S10 phosphoryla-
tion and H3K14 acetylation were also in-
creased 24 h after training, but
significantly more than in control mice
(Fig. 6a, gray lines). In addition to H3S10
phosphorylation and H3K14 acetylation,
H3K36 trimethylation was also signifi-
cantly enhanced after training, whereas
H3K9 and H4K5 acetylation was de-
creased. Importantly, however, the net
difference in histone PTMs observed in
the mutant mice before training persisted
for H3S10 phosphorylation, H3K14/
H4K5 acetylation, and H3K36 trimethy-
lation after training and correlated with a
significant increase in CREB expression
and LTM when compared with control
mice (Fig. 6b). Finally, CREB phosphory-
lation at S133 was also higher in the
mutant mice after training (Fig. 6c), con-
sistent with previous findings that CREB
phosphorylation is activity dependent and induced in LTM(Silva
et al., 1998). Overall, these results suggest that H3S10 phos-
phorylation and H3K14 acetylation at the CREB promoter
correlate with CREB expression and that, in combination with
H4K5 acetylation and H3K36 trimethylation, they further po-
tentiate CREB expression and improve LTM.
Discussion
The present findings reveal that the nuclear pool of the protein
phosphatase PP1 in adult neurons plays a key role in the epige-
netic regulation of memory formation in mammals. They dem-
onstrate for the first time that nuclear PP1 is present at the
chromatin in brain cells, in which it regulates histone PTMs by
acting both directly and through complexes with components of
the epigenetic machinery including HDAC1 and JMJD2A. The
selective inhibition of nuclear PP1 in neurons not only interferes
with the activity of PP1 but also with these complexes and, con-
sequently, alters multiple histone PTMs including phosphoryla-
tion, acetylation, and methylation at the promoter of specific
genes likeCREB andNF-B. This, in turn, alters the expression of
these genes and is associated with improved LTM.
Overall, the present data highlight the importance of combi-
natorial histones PTMs for the regulation of memory genes and
demonstrates that they are controlled by PP1. Further to reveal-
ing a hitherto-unknown role for PP1 in neuronal cells, the data
show that nuclear PP1 has distinct functions from synaptic PP1
(Hu et al., 2006; Jouvenceau et al., 2006; Mansuy and Shenolikar,
2006) andunderscore the importanceofPP1 inmultiple fundamen-
tal cellular processes and of its subcellular compartmentalization
(Virshup and Shenolikar, 2009). These results significantly extend
recent reports showing that the protein kinasesMSK1, ERK/MAPK,
and IB are involved in the control of histone PTMs in memory
(Levenson et al., 2004; Chwang et al., 2006, 2007; Lubin and Sweatt,
2007) and suggest that PP1 is the primary PP that counteracts these
kinases. Together, they strengthen the concept that the balance be-
tween protein kinases and phosphatases in the brain is critical for
cognitive processes (Lee and Silva, 2009) by showing that this bal-
ance also operates at the level of the chromatin.
This study is also the first to demonstrate the combinatorial
and simultaneous regulation of histone phosphorylation, acety-
lation, and methylation, three PTMs known to be induced by
learning (Guan et al., 2002; Alarco´n et al., 2004; Levenson et al.,
2004; Chwang et al., 2006, 2007; Bredy et al., 2007; Fischer et al.,
2007; Lubin and Sweatt, 2007; Lubin et al., 2008), by PP1-
Figure6. Changes inhistonePTMsafter object recognition.a, ChIP analyses ofH3S10phosphorylation,H3K9,H3K14, andH4K5
acetylation, and H3K36 trimethylation at the CREB promoter in the hippocampus after novel object recognition (control naive and
trained,n3–4;NIPP1*-EGFPnaive and trained,n3–4). pH3S10, naive, control versusmutant, t(5)7.4,p0.01; trained,
control versus mutant, t(5) 4.3, p 0.05; control, trained versus naive, t(5) 5.87, p 0.01; mutant, trained versus naive,
t(5) 4.44, p 0.05; difference between slopes, p 0.05. AcH3K9, naive, control versus mutant, n.s.; trained, control versus
mutant, n.s.; control, trainedversusnaive, n.s;mutant, trainedversusnaive, t(5)4.91,p0.01; differencebetween slopes,p
0.05. AcH3K14, naive, control versus mutant, t(4) 8.58, p 0.01; trained, control versus mutant, t(5) 12.01, p 0.001;
control, trained versus naive, t(5) 7.07, p 0.01; mutant, trained versus naive, t(5) 5.42, p 0.05; difference between
slopes, p 0.05. AcH4K5, naive, control versus mutant, t(5) 6.29, p 0.01; trained, control versus mutant, t(5) 3.42, p
0.05; control, trained versus naive, n.s.; mutant, trained versus naive, t(5) 5.22, p 0.01; difference between slopes, p 0.05.
3meH3K36, naive, control versus mutant, t(5) 4.85, p 0.01; trained, control versus mutant, t(4) 10.06, p 0.01; control,
trained versus naive, n.s.; mutant, trained versus naive, t(5) 5.45, p 0.01; difference between slopes, p 0.01. Data are
normalized to control naive littermates. b, Quantitative RT-PCR showing CREB mRNA expression over time (control naive and
trained, n 5–8; NIPP1*-EGFP naive and trained, n 5–8; naive, control vs mutant, F(1,8) 20.76, p 0.01; trained, control
vsmutant, F(1,8) 5.7, p 0.05; control, trained vs naive, F(1,8) 18.13, p 0.01;mutant, trained vs naive, F(1,8) 5.15, p
0.05). Data are normalized to control naive littermates. c, Quantitative analysis (below) of the ratio between phosphorylated CREB
and total CREB in the hippocampus inmutant and controlmice; representativeWestern blots are shown above bar charts.-Actin
was used as an internal control anddatawere normalized to control littermates. Naive, control versusmutant, n.s.; trained, control
versus mutant, F(1,6) 6.54, p 0.05; control, trained versus naive, n.s.; mutant, trained versus naive, F(1,8) 8.64, p 0.05.
The asterisks indicate a significant difference betweenmutant and control mice; the hash signs a significant difference within the
same treatment (mutant or control) group. Error bars indicate SEM. *p 0.05, **p 0.01, ***p 0.001.
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dependentmechanisms. It shows that gene transcription (e.g., for
CREB) and LTM are facilitated by H3S10 phosphorylation, and
H3K14 andH2B acetylation (Alarco´n et al., 2004; Levenson et al.,
2004; Chwang et al., 2006, 2007), as well as by H4K5 acetylation
and H3K36 trimethylation, two newly
identified PTMs. This transcriptional sig-
nature appears to be controlled by cross
talk mechanisms between these histone
PTMs that are coordinated by PP1 (Fig.
7). Our data further suggest that these hi-
stone PTMs may not all be required for
the activation of CREB transcription
since, in control mice, only H3S10 phos-
phorylation andH3K14 acetylation corre-
late with increased gene expression.
However, a full combination may be
needed to further raise or prolong gene
transcription, possibly through more sus-
tained decondensation of the chromatin.
In this respect, histone methylation may
be of particular importance since this
PTM is implicated in the maintenance of
the transcriptional status of genes (Shilati-
fard, 2006) and could thus contribute to
the stability of transcriptional signatures
in LTM. However, it is important to note
that, although our data identify one such
signature at the CREB promoter, other
signatures on other genes likely also exist.
Finally, it should be noted that the de-
crease in H4K5 and H3K9 acetylation in-
duced by training in the mutant mice is
mechanistically not understood but may
involve a negative cis-cross talk between
histone PTMs from S10 to K9 on H3
(Edmondson et al., 2002) and, likewise, a
yet-unidentified trans-cross talk between
H3S10 andH4K5 (Fig. 7).
The mechanisms that target PP1 and
control its activity at the chromatin are
not fully elucidated but are likely to in-
volve the association of PP1 with specific
binding partners such as PNUTS (phos-
phatase 1 nuclear targeting subunit) in
neurons (Ceulemans and Bollen, 2004;
Bennett, 2005). Importantly, in the mu-
tant mice, the substrate specificity of nu-
clear PP1 was apparently not disturbed by
PP1 inhibition since the phosphorylation
of nonhistone nuclear proteins or of
synaptic proteins was not altered—only
CREB phosphorylation after training was
increased, consistentwith the fact that this
PTM is activity dependent (Silva et al.,
1998). This specificity is thought to result
from the endogenous nature of NIPP1*,
which is a fragment of a natural inhibitor
that targets PP1 specifically without inter-
fering with its subcellular localization. Its
moderate expression achieved by our trans-
genic system induced a physiological range
of PP1 inhibition (40–60%) (Genoux et al.,
2002), which most likely avoids off-target
effects. In this respect, theobservation thatHDAC1phosphorylation
(on S421) was not altered despite its close association with PP1,
suggests that this residue is not dephosphorylated by PP1 in neu-
rons. SinceHDAC1 and PP1 are both fully functional when phys-
Figure7. Model foraPP1-dependenthistonecode for thecontrolofgenetranscription.Forgenesilencing,PP1binds to thechromatin
where it dephosphorylates histones and negatively controls histone acetylation and methylation through association with HDACs and
JMJD2A.ThesechangesenhancechromatincondensationandpreventRNApolymeraseII(Pol II),TATAboxbindingprotein(TBP),andother
transcription factors (TFs) frombinding to the chromatin. For geneactivation, PP1 is inhibitedby endogenous inhibitors suchasNIPP1*or
targeting partners. This favors histone phosphorylation (specifically onH3S10),which ismediated by protein kinases (PKs) such asMSK1,
ERK1, or PKA (Canettieri et al., 2003; Chwanget al., 2006, 2007). PP1 inhibition further leads to thedissociationof PP1 fromHDACs,which
reducesHDACactivityandthus increaseshistoneacetylation (specificallyonH3K14andH4K5),most likelywith theaidofHATs suchasCBP
(Alarco´n et al., 2004; Korzus et al., 2004) andp300 (Oliveira et al., 2007). These changes are accompaniedby an increase inmethylationof
H3K36,which is likely to result froma reduced interactionbetweenPP1and JMJD2Aandasubsequent reduction in theactivityof JMJD2A.
Other members of the epigenetic machinery such as histone methyltransferases (HMTs) are presumably also involved. Together, these
changes trigger chromatin decondensation and increase its accessibility to the transcriptional machinery. Bottom part, in gray, histone
residues assessed for PTMs but not found to be differentially regulated; in green, histone PTMs, which depend on nuclear PP1. The thick
arrowrepresentsawell establishedcross talkbetweenH3S10phosphorylationandH3K14acetylation in thecontextofmemory formation
(Chwangetal.,2006,2007).Thethinarrows illustratepotential cross talkssuggestedbythepresentdata.Forclarity, thecross talkbetween
these residues and the acetylated H2B is omitted. Note that some of these cross talks have been reported in other model organisms
(Kouzarides, 2007; LathamandDent, 2007), but not in the adultmammalian brain.
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ically associated in an enzymatic complex (Canettieri et al., 2003),
the decrease inHDAC activitymay result from the complex being dis-
rupteduponnuclearPP1 inhibition.This is reminiscentof theobserva-
tion that HDAC inhibitors such as TSA (trichostatin A) also disrupt
HDAC–PP1 complexes and thereby downregulate HDAC activity
(Brush et al., 2004).
Together, the present data identify a novel mechanism for
chromatin remodeling and epigenetic regulation of LTM forma-
tion that depends on nuclear PP1. They demonstrate that,
through phosphatase inhibition, this mechanism is amenable to
positive modulation for memory improvement, which expands
previous reports showing that memory defects and cognitive de-
cline caused by perturbed chromatin remodeling can be im-
proved by HDAC inhibition (Abel and Zukin, 2008). These
findings may therefore provide new potential targets for the ap-
plication of “epigeneticmedicine” for treatingmemory disorders
and cognitive decline.
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